Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWI
276
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $59M | 0.06% |
1,558,418
+151,111
| +11% | +$5.27M |
|
277
BHP
BHP
$212B
| $57.9M | 0.06% |
1,003,549
-481,032
| -32% | -$27.8M |
|
|
CHS
278
DELISTED
Chicos FAS, Inc.
CHS
| $57.5M | 0.06% |
3,053,456
-84,788
| -3% | -$1.5M |
|
279
Patterson-UTI
PTEN
$3.57B
| $57.2M | 0.06% |
+2,258,544
| New | +$54.1M |
|
280
Deckers Outdoor
DECK
$14.1B
| $56.8M | 0.06% |
4,035,546
-174,648
| -4% | -$2.15M |
|
|
QLIK
281
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $56.6M | 0.06% |
2,124,727
+23,386
| +1% | +$646K |
|
282
Analog Devices
ADI
$175B
| $56.5M | 0.06% |
1,108,655
-8,613
| -0.8% | -$420K |
|
283
Corpay
CPAY
$25.7B
| $56.3M | 0.06% |
480,781
+87,052
| +22% | +$10M |
|
284
Kroger
KR
$36.6B
| $56.3M | 0.06% |
2,849,464
+975,854
| +52% | +$20.2M |
|
|
WSTC
285
DELISTED
West Corporation
WSTC
| $56.1M | 0.06% |
2,180,669
+107,612
| +5% | +$2.52M |
|
286
Darling Ingredients
DAR
$9.29B
| $55.9M | 0.05% |
2,676,121
+2,636,433
| +6,643% | +$56.4M |
|
287
RBC Bearings
RBC
$17.5B
| $55.5M | 0.05% |
784,541
-167,740
| -18% | -$11.3M |
|
288
Charter Communications
CHTR
$17.4B
| $54.9M | 0.05% |
401,293
| – | – |
|
|
GNMK
289
DELISTED
GenMark Diagnostics, Inc
GNMK
| $54.7M | 0.05% |
4,108,676
-112,946
| -3% | -$1.37M |
|
|
WNR
290
DELISTED
Western Refining Inc
WNR
| $54.6M | 0.05% |
1,286,365
+709,658
| +123% | +$25.5M |
|
291
AES
AES
$10.6B
| $53.8M | 0.05% |
3,707,037
| – | – |
|
|
KYTH
292
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $53.6M | 0.05% |
1,438,615
+259,364
| +22% | +$10.8M |
|
|
LUX
293
DELISTED
Luxottica Group
LUX
| $53.4M | 0.05% |
991,188
-135,877
| -12% | -$7.05M |
|
294
Fortinet
FTNT
$113B
| $53.3M | 0.05% |
13,938,025
-420,310
| -3% | -$1.64M |
|
|
AXE
295
DELISTED
Anixter International Inc
AXE
| $53.1M | 0.05% |
591,460
-30,431
| -5% | -$2.65M |
|
296
IMAX
IMAX
$2.64B
| $52.9M | 0.05% |
1,794,714
+772,188
| +76% | +$22.2M |
|
297
Heartland Express
HTLD
$1.01B
| $52.2M | 0.05% |
2,660,317
-1,010,637
| -28% | -$16.6M |
|
298
Devon Energy
DVN
$51.2B
| $52.2M | 0.05% |
843,274
+187,289
| +29% | +$11.5M |
|
|
GPOR
299
DELISTED
Gulfport Energy Corp.
GPOR
| $51.9M | 0.05% |
822,516
-280,915
| -25% | -$17M |
|
|
RATE
300
DELISTED
Bankrate Inc
RATE
| $51.9M | 0.05% |
2,894,847
+1,932,265
| +201% | +$37.3M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.